FDA Review Threatens Abortion Pill Access
Update: 2025-11-25
Description
Federal rules for the abortion pill mifepristone remain unchanged, but a safety review by the FDA has created uncertainty. This review could impact distribution and access, with state laws and lawsuits also changing the landscape. Drugmakers are expanding into other areas, possibly preparing for market changes. Human reactions vary, with experts calling the FDA review junk science. New findings show a controversial safety review could lead to stricter rules or even removal of the drug from the market. The situation highlights a complex interplay of federal and state actions, creating a challenging environment for providers and patients.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
